Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation

Arsenic trioxide (As(2)O(3)) is one of the most effective therapeutic agents used for patients with acute promyelocytic leukemia (APL). The probable explanation for As(2)O(3)-induced cell differentiation is the direct targeting of PML-RARα oncoprotein by As(2)O(3), which results in initiation of PML...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Wang, Qian Qian, Zhou, Xin Yi, Zhang, Yan Fang, Bu, Na, Zhou, Jin, Cao, Feng Lin, Naranmandura, Hua
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694856/
https://ncbi.nlm.nih.gov/pubmed/26213848
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares